Indications and uses
Use on affected areas for relief of itching, irritation, redness, flaking and scaling associated with Eczema & Psoriasis.
Use on affected areas for relief of itching, irritation, redness, flaking and scaling associated with Eczema & Psoriasis.
Apply to affected skin 2-3 times daily Smooth in gently The smallest effective dose should be used Patch test recommended on sensitive skin Suitable for use on children 2 years of age and older
Store between 50°- 86°F in a dry place
Drug Facts
Use on affected areas for relief of itching, irritation, redness, flaking and scaling associated with Eczema & Psoriasis.
For external use only.
Keep out of the reach of children.
Store between 50°- 86°F in a dry place
Aloe Barbadensis Leaf Juice, Anthemis Nobilis (Chamomile) Oil, Butyrospermum Parkii (Shea) Butter, Capric/Caprylic Triglyceride, Caprylyl Glycol, Cetearyl Alcohol, Ceteareth-20, Glycyrrhiza Glabra (Licorice) Root Extract, Lavandula Angustifolia (Lavender) Oil, Oenothera Biennis (Evening Primrose) Oil, Persea Gratissima (Avocado) Oil, Phenoxyethanol, Sorbic Acid, Theobroma Cacao (Cocoa) Seed Butter, Tocopheryl Acetate, Water, Zinc Oxide
NDC: 43251-2241-1
natralia™
NATURALLY AUSTRALIAN
Eczema &
Psoriasis
Cream
RASH RELIEF
BEFORE
AFTER
Proud Supporter
eczema
association
australasia
eaa
SUITABLE FOR CHILDREN
Homeopathic
Net Wt 2 oz (56g)

| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Graphite | ACTIVE INGREDIENT | 4QQN74LH4O | 4 | |
| Potassium Sulfate | ACTIVE INGREDIENT | 1K573LC5TV | 4 | |
| Sodium Borate | ACTIVE INGREDIENT | 91MBZ8H3QO | 4 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 4 | |
| Borate ion | ACTIVE MOIETY | 44OAE30D22 | 4 | |
| Graphite | ACTIVE MOIETY | 4QQN74LH4O | 4 | |
| Sodium Cation | ACTIVE MOIETY | LYR4M0NH37 | 4 | |
| SULFATE ION | ACTIVE MOIETY | 7IS9N8KPMG | 4 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 4 | |
| Avocado Oil | INACTIVE INGREDIENT | 6VNO72PFC1 | 4 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 4 | |
| Cetearyl Glucoside | INACTIVE INGREDIENT | 09FUA47KNA | 4 | |
| Cetostearyl Alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 4 | |
| Chamaemelum Nobile Flower Oil | INACTIVE INGREDIENT | UB27587839 | 4 | |
| Cocoa Butter | INACTIVE INGREDIENT | 512OYT1CRR | 4 | |
| Evening Primrose Oil | INACTIVE INGREDIENT | 3Q9L08K71N | 4 | |
| Glycyrrhiza Glabra | INACTIVE INGREDIENT | 2788Z9758H | 4 | |
| Lavandula Angustifolia Flower | INACTIVE INGREDIENT | 19AH1RAF4M | 4 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 4 | |
| Shea Butter | INACTIVE INGREDIENT | K49155WL9Y | 4 | |
| Sorbic Acid | INACTIVE INGREDIENT | X045WJ989B | 4 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 4 | |
| Zinc Oxide | INACTIVE INGREDIENT | SOI2LOH54Z | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43251-2241 | 43251-2241-1, 43251-2241-2 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, DELAYED RELEASE / ORAL | 0.03 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET / SUBLINGUAL | 0.16 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| Cocoa Butter | COCOA BUTTER | 512OYT1CRR | SUPPOSITORY / RECTAL | 2280 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SUSPENSION / ORAL | 40 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / VAGINAL | 6 mg | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SYRUP / ORAL | 80 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | GEL / TOPICAL | 2 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | CONCENTRATE / ORAL | 1 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 1 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SOLUTION / OPHTHALMIC | 0.2 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SUPPOSITORY / VAGINAL | NA | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, FILM COATED / ORAL | 5 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | EMULSION / OPHTHALMIC | 1 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SOLUTION / ORAL | 80 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | OINTMENT / TOPICAL | 0.1 %w/w | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | AEROSOL, FOAM / TOPICAL | 6 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | CREAM / TOPICAL | 14 mg | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| Shea Butter | SHEA BUTTER | K49155WL9Y | LOTION / TOPICAL | 2340 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SOLUTION/ DROPS / OPHTHALMIC | 0.2 %w/v | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | LOTION / TOPICAL | 4 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, COATED / ORAL | 1 mg | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET / ORAL | 10 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, CHEWABLE / ORAL | NA | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8178bf6e-c7d4-4f2d-83ef-0dba183ce281 | 90705b9c-4f2b-48da-84de-711dd824595e | 2020-12-15 | Warnings | 8178bf6e-c7d4-4f2d-83ef-0dba183ce281 90705b9c-4f2b-48da-84de-711dd824595e |
Adverse event summaries are temporarily unavailable. Other product information remains available.